 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
||
 |
 |
 |
|
|||||||
 |
|
|||||||||
 |
|
|||||||||
Alert Number 166
Date: June 7, 2024
More than two years ago we published an article titled The Dark Side of Epoetin, in which we discussed the potential serious risks of over-indulging in epo drugs (brand names Epogen, Procrit and Aranesp). The reason for re-visiting the subject now is that the latest information published in the May 17, 2024 issue of the Journal of the National Cancer Institute suggests the risks are even greater than we thought they were.
Indiscriminate use of epo drugs may cause your cancer to progress faster, you may be more at risk of heart attacks and stroke, and the ultimate penalty, they may even decrease your overall survival!
I hope I have got your attention with this short introduction to the subject. You can read the full review at The Dark Side of EPO - Getting Darker.
Be well,
Chaya
______
NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
———
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright Notice:
Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.
———
